Last $8.43 USD
Change Today +0.23 / 2.80%
Volume 11.9K
IRIX On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GM
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

iridex corp (IRIX) Snapshot

Open
$8.32
Previous Close
$8.20
Day High
$8.58
Day Low
$8.32
52 Week High
01/22/14 - $11.00
52 Week Low
10/22/14 - $6.41
Market Cap
83.0M
Average Volume 10 Days
17.8K
EPS TTM
$0.17
Shares Outstanding
9.8M
EX-Date
--
P/E TM
49.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for IRIDEX CORP (IRIX)

Related News

No related news articles were found.

iridex corp (IRIX) Related Businessweek News

No Related Businessweek News Found

iridex corp (IRIX) Details

IRIDEX Corporation develops, manufactures, markets, sells, and services medical laser systems and associated instrumentation for the treatment of the sight-threatening eye diseases worldwide. Its ophthalmology products consist of laser consoles, such as visible (yellow) photocoagulator console, infrared photocoagulator consoles, micropulse enabled consoles, and multi-wavelength laser system configurations. The company also provides ophthalmic delivery devices and other products, such as TxCell scanning laser delivery systems; TruFocus laser indirect ophthalmoscopes; slit lamp adapters; and operating microscope adapters. In addition, it offers EndoProbe, a fiber optic delivery device used for endophotocoagulation, a retinal treatment procedure; G-Probe, a sterile consumable multi-use product used in procedures to treat medically and surgically uncontrolled glaucoma; and DioPexy Probe, a hand-held instrument used in procedures to treat retinal tears. Further, the company provides GreenTip Soft Tip Cannula, a sterile disposable product, which allows surgeons to visualize and access the proximity of the retina while performing a fluid air exchange during a vitrectomy procedure; and MoistAir in-line air humidifier that provides humidified air to the eye during fluid air exchange. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It sells and markets its products through a direct sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.

101 Employees
Last Reported Date: 03/27/14
Founded in 1989

iridex corp (IRIX) Top Compensated Officers

Chairman of the Board, Chief Executive Office...
Total Annual Compensation: $200.0K
Chief Financial Officer, Chief Operating Offi...
Total Annual Compensation: $284.7K
Vice President of Operations
Total Annual Compensation: $138.5K
Compensation as of Fiscal Year 2013.

iridex corp (IRIX) Key Developments

IRIDEX Corporation Secures Large Tender from Government of Zambia for Ophthalmology Laser Equipment

IRIDEX Corporation announced that it has been awarded a competitive tender for more than $350,000 in ophthalmology laser equipment by the government of Zambia.

IRIDEX Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 27, 2014; Provides Earnings Guidance for the Fourth Quarter of 2014

IRIDEX Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended September 27, 2014. For the quarter, the company reported net income of $490,000 or $0.05 per basic and diluted share on total revenues of $10,118,000 compared to net income of $530,000 or $0.05 per basic and diluted share on total revenues of $9,526,000 a year ago. Income from operations was $606,000 against $665,000 a year ago. Income from continuing operations before provision for income taxes was $494,000 against $580,000 a year ago. For the nine months, the company reported net income of $1,274,000 or $0.12 per diluted share on total revenues of $31,036,000 compared to net income of $1,819,000 or $0.18 per basic and diluted share on total revenues of $27,675,000 a year ago. Income from operations was $1,603,000 against $2,077,000 a year ago. Income from continuing operations before provision for income taxes was $1,303,000 against $1,877,000 a year ago. For the fourth quarter, the company expects to achieve revenue of $10.9 million to $11.2 million, which compares to revenues of $10.6 million for the 2013 fourth quarter. Gross margin is anticipated to come in between 49% and 51%, and operating expenses are expected to be $4.7 million to $4.9 million.

IRIDEX Corporation to Report Q3, 2014 Results on Oct 30, 2014

IRIDEX Corporation announced that they will report Q3, 2014 results at 5:00 PM, US Eastern Standard Time on Oct 30, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IRIX:US $8.43 USD +0.23

IRIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cutera Inc $9.89 USD -0.17
Ellex Medical Lasers Ltd A$0.32 AUD +0.01
Lutronic Corp 26,200 KRW -450.00
STAAR Surgical Co $9.15 USD +0.30
Synergetics USA Inc $3.53 USD -0.06
View Industry Companies
 

Industry Analysis

IRIX

Industry Average

Valuation IRIX Industry Range
Price/Earnings 52.0x
Price/Sales 2.0x
Price/Book 3.2x
Price/Cash Flow 49.2x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IRIDEX CORP, please visit www.iridex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.